VVOS - Vivos Therapeutics Inc. (VVOS) Q1 2024 Earnings Call Transcript

2024-05-17 21:02:06 ET

Vivos Therapeutics, Inc. (VVOS)

Q1 2024 Results Conference Call

May 14, 2024 05:00 PM ET

Company Participants

Julie Gannon - Investor Relations Officer

Kirk Huntsman - Chairman & Chief Executive Officer

Brad Amman - Chief Financial Officer

Conference Call Participants

Lucas Ward - Ascendiant Capital Markets

Presentation

Operator

Good day, everyone, and welcome to the Vivos Therapeutics First Quarter 2024 Earnings Conference Call. At this time, participants are in a listen-only mode. A question-and-answer session will follow management's remarks. This conference is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.

I will now hand the call over to Julie Gannon, Vivos' Investor Relations Officer for introductions and reading of the safe harbor statement. Please go ahead.

Julie Gannon

Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com....

For further details see: